About this trial
The investigators are studying whether metabolic abnormalities in calf (leg) muscle in older people with and others without HIV are associated with decreased abilities to exercise.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Participants who are >= 60 years of age
HIV serostatus positive participants on stable antiretroviral therapy (ART) (no regimen change in last month) with undetectable HIV viral load (<100 copies).
HIV serostatus negative participants
Disqualifiers
Unable to understand the risks, benefits, and alternatives of participation and give meaningful consent
Contraindications to MRI
Significant cardiovascular, pulmonary or musculoskeletal or orthopedic disease that significantly limits exercise capacity
Significant lower extremity peripheral vascular disease.
Trial population
People with and without HIV, ages 60 and above will be enrolled
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Maximal mitochondrial oxidative capacity (VmaxPCr)
Maximal oxidative capacity of leg muscle measured by 31P Magnetic Resonance Spectroscopy (MRS)
Rate of PCr decline during plantar flexion exercise
Six minute walk distance
Secondary outcomes
Skeletal muscle fat content
Gait speed
Frailty status (as measured by the Fried Frailty Index)
Fried frailty index described in J Gerontol A bill Sci-Fi Med Sci-Fi 2001;56:M146-56
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Johns Hopkins University
Lead sponsor
National Institute on Aging (NIA)
Collaborator